Frontier Bio
Lab-Grown Human Tissue To Eliminate The Organ Transplant Waitlist
Frontier Bio operates in enterprise and deep tech based in Hayward, CA, USA, founded in 2025.
Profile
Frontier Bio creates lab-grown human tissues as an ethical alternative to animal studies and is paving the way to eliminate the organ transplant waitlist. We're unleashing the power of stem cells to revolutionize regenerative medicine. Key Highlights: - $5.5M cumulative sales - Backed by a Nobel Laureate - $3.9M prior funding + NSF SBIR grant - Profitable last year
The company sits in the enterprise and deep tech segment, where it competes on its core product or service.
The company is recorded as being based in Hayward, CA, USA.
It is recorded at the Seed stage.
Recorded headcount: 1-10 employees.
It has disclosed roughly $6M in funding.
| Sector | Enterprise and deep tech |
|---|---|
| Headquarters | Hayward, CA, USA |
| Country | United States |
| Founded | 2025 |
| Employees | 1-10 |
| Stage | Seed |
| Total funding | $6,025,000 |
Website: www.frontierbio.com
Browse related
Create a free account